Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIANO: Semaglutide for the Assessment of Adrenal Function
NCT06608433Completed
- Sponsor
- University Hospital Basel
- Start
- Jan 2025
- Primary completion
- Oct 2025
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of semaglutide in adrenal insufficiency (AI) and adrenal insufficiency (2 arms), sponsored by University Hospital Basel. Primary endpoint: Change in serum cortisol at 210 minutes. Started Jan 2025; status: completed.
02
Drugs
03
Conditions
adrenal insufficiency (AI)adrenal insufficiency
Beyond the preview
Go deeper on NCT06608433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06608433.